Patents by Inventor Lee Heil CHAE

Lee Heil CHAE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230354864
    Abstract: This disclosure relates to methods and compositions with enhanced levels of one or more tyramine containing hydroxycinnamic acid amides. Also disclosed herein are methods for producing a consumable product with enhanced levels of a tyramine containing hydroxycinnamic acid amide. Some embodiments relate to a composition enriched with a tyramine containing hydroxycinnamic acid.
    Type: Application
    Filed: May 12, 2023
    Publication date: November 9, 2023
    Inventors: Lee Heil Chae, James Flatt, Alexandra Marcela Herrmann, Gabriel Navarro, Jessica Leigh Ochoa
  • Publication number: 20230270699
    Abstract: A method for modulating metabolism is provided which includes the step of providing a consumable composition including an extract containing a compound of Formula I to a subject in need thereof thereby modulating the subject's metabolism and addressing the underlying pathogenesis of metabolic disorders, such as nonalcoholic fatty liver disease, nonalcoholic steatohepatitis and type II diabetes mellitus.
    Type: Application
    Filed: May 8, 2023
    Publication date: August 31, 2023
    Inventor: Lee Heil Chae
  • Patent number: 11647776
    Abstract: This disclosure relates to methods and compositions with enhanced levels of one or more tyramine containing hydroxycinnamic acid amides. Also disclosed herein are methods for producing a consumable product with enhanced levels of a tyramine containing hydroxycinnamic acid amide. Some embodiments relate to a composition enriched with a tyramine containing hydroxycinnamic acid.
    Type: Grant
    Filed: November 12, 2021
    Date of Patent: May 16, 2023
    Assignee: Brightseed, Inc.
    Inventors: Lee Heil Chae, James Flatt, Alexandra Marcela Herrmann, Gabriel Navarro, Jessica Leigh Ochoa
  • Patent number: 11642323
    Abstract: A method for modulating metabolism is provided which includes the step of providing a consumable composition including an extract containing a compound of Formula I to a subject in need thereof thereby modulating the subject's metabolism and addressing the underlying pathogenesis of metabolic disorders, such as nonalcoholic fatty liver disease, nonalcoholic steatohepatitis and type II diabetes mellitus.
    Type: Grant
    Filed: July 20, 2022
    Date of Patent: May 9, 2023
    Assignee: Brightseed, Inc.
    Inventor: Lee Heil Chae
  • Publication number: 20220370383
    Abstract: A method for modulating metabolism is provided which includes the step of providing a consumable composition including an extract containing a compound of Formula Ito a subject in need thereof thereby modulating the subject's metabolism and addressing the underlying pathogenesis of metabolic disorders, such as nonalcoholic fatty liver disease, nonalcoholic steatohepatitis and type II diabetes mellitus.
    Type: Application
    Filed: July 20, 2022
    Publication date: November 24, 2022
    Inventor: Lee Heil CHAE
  • Publication number: 20220362182
    Abstract: Disclosed herein are methods for reversing hepatic steatosis by providing a consumable composition. Some embodiments provided include, for example, administering a compound of Formula (I) or compound of Formula (II). Some embodiments provide the composition is formulated as a dietary supplement, food ingredient or additive, a medical food, nutraceutical or pharmaceutical composition.
    Type: Application
    Filed: July 12, 2022
    Publication date: November 17, 2022
    Applicant: SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE
    Inventors: Lee Heil CHAE, Fred LEVINE
  • Publication number: 20220296542
    Abstract: Disclosed herein are methods for improving digestive health by providing a consumable composition. Some embodiments provided include, for example, administering a compound of Formula (I) or compound of Formula (II). Some embodiments provide the composition is formulated as a dietary supplement, food ingredient or additive, a medical food, nutraceutical or pharmaceutical composition.
    Type: Application
    Filed: May 31, 2022
    Publication date: September 22, 2022
    Inventors: Lee Heil Chae, Fred Levine
  • Patent number: 11382880
    Abstract: Disclosed herein are methods for improving digestive health by providing a consumable composition. Some embodiments provided include, for example, administering a compound of Formula (I) or compound of Formula (II). Some embodiments provide the composition is formulated as a dietary supplement, food ingredient or additive, a medical food, nutraceutical or pharmaceutical composition.
    Type: Grant
    Filed: January 4, 2021
    Date of Patent: July 12, 2022
    Assignees: Brightseed, Inc., Sanford-Burnham Medical Research Institute
    Inventors: Lee Heil Chae, Fred Levine
  • Publication number: 20220062207
    Abstract: A method for modulating metabolism is provided which includes the step of providing a consumable composition including an extract containing a compound of Formula I to a subject in need thereof thereby modulating the subject's metabolism and addressing the underlying pathogenesis of metabolic disorders, such as nonalcoholic fatty liver disease, nonalcoholic steatohepatitis and type II diabetes mellitus.
    Type: Application
    Filed: October 14, 2021
    Publication date: March 3, 2022
    Inventor: Lee Heil CHAE
  • Publication number: 20220061370
    Abstract: This disclosure relates to methods and compositions with enhanced levels of one or more tyramine containing hydroxycinnamic acid amides. Also disclosed herein are methods for producing a consumable product with enhanced levels of a tyramine containing hydroxycinnamic acid amide. Some embodiments relate to a composition enriched with a tyramine containing hydroxycinnamic acid.
    Type: Application
    Filed: November 12, 2021
    Publication date: March 3, 2022
    Inventors: Lee Heil CHAE, James Flatt, Alexandra Marcela Herrmann, Gabriel Navarro, Jessica Leigh Ochoa
  • Patent number: 11173136
    Abstract: A method for modulating metabolism is provided which includes the step of providing a consumable composition including an extract containing a compound of Formula I to a subject in need thereof thereby modulating the subject's metabolism and addressing the underlying pathogenesis of metabolic disorders, such as nonalcoholic fatty liver disease, nonalcoholic steatohepatitis and type II diabetes mellitus.
    Type: Grant
    Filed: January 10, 2019
    Date of Patent: November 16, 2021
    Assignee: Brightseed, Inc.
    Inventor: Lee Heil Chae
  • Publication number: 20210128499
    Abstract: Disclosed herein are methods for improving digestive health by providing a consumable composition. Some embodiments provided include, for example, administering a compound of Formula (I) or compound of Formula (II). Some embodiments provide the composition is formulated as a dietary supplement, food ingredient or additive, a medical food, nutraceutical or pharmaceutical composition.
    Type: Application
    Filed: January 4, 2021
    Publication date: May 6, 2021
    Inventors: Lee Heil Chae, Fred Levine
  • Publication number: 20200368186
    Abstract: A method for modulating metabolism is provided which includes the step of providing a consumable composition including an extract containing a compound of Formula Ito a subject in need thereof thereby modulating the subject's metabolism and addressing the underlying pathogenesis of metabolic disorders, such as nonalcoholic fatty liver disease, nonalcoholic steatohepatitis and type II diabetes mellitus.
    Type: Application
    Filed: January 10, 2019
    Publication date: November 26, 2020
    Inventor: Lee Heil CHAE
  • Publication number: 20190375705
    Abstract: Tyramine containing hydroxycinnamic acid amide derivatives are provided as are methods of using the same in modulating metabolism and addressing the underlying pathogenesis of metabolic disorders, such as nonalcoholic fatty liver disease, nonalcoholic steatohepatitis and type II diabetes mellitus.
    Type: Application
    Filed: July 12, 2019
    Publication date: December 12, 2019
    Inventors: Lee Heil CHAE, Jessica Leigh OCHOA, Dennis SOLAS